Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041757 | SCV000065453 | benign | not specified | 2012-05-15 | criteria provided, single submitter | clinical testing | Ser4772Phe in Exon 65 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 1.1% (41/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs149222801). |
Invitae | RCV000894587 | SCV001038580 | benign | not provided | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000894587 | SCV001765338 | likely benign | not provided | 2020-10-29 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25468891) |
Genome- |
RCV003450789 | SCV004183082 | likely benign | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001826591 | SCV004183083 | likely benign | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV000894587 | SCV002034345 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041757 | SCV002038022 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001826591 | SCV002088230 | likely benign | Usher syndrome type 2A | 2021-08-27 | no assertion criteria provided | clinical testing |